Biotech in Switzerland – The Success Story of PaxVax

Source: Newly Swissed
Publication Date: September 1, 2015
Visit Source

PaxVax acquires Crucell Switzerland and saves nearly 80 high-quality manufacturing jobs. Looking ahead, the company plans to increase the site’s production as it brings new vaccines to market.